Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
My69z's Profile
Displaying 401-450 of 1150 result(s).
CYDY CytoDyn Inc
02/02/2025 10:05:10 PM
"(although joint or separate MASH d (1)
CYDY CytoDyn Inc
02/02/2025 8:30:54 PM
Glaxosmithkline IPF study -- This w (7)
CYDY CytoDyn Inc
01/28/2025 9:28:21 PM
Now let's get GF/ViiV to human tria (3)
CYDY CytoDyn Inc
01/28/2025 8:02:55 PM
Leronlimab: New PrEP & treating. In (11)
CYDY CytoDyn Inc
01/28/2025 1:11:29 AM
Why Bill Gates "cure" is us.. short (8)
CYDY CytoDyn Inc
01/27/2025 9:28:58 AM
Max's worldwide Cytodyn initatives, (3)
CYDY CytoDyn Inc
01/27/2025 8:52:17 AM
Read more on the EO. Looking @ prog (5)
CYDY CytoDyn Inc
01/26/2025 7:50:37 AM
Triple Cure ART+ bnAb+LL needs 1 th (7)
CYDY CytoDyn Inc
01/25/2025 7:42:11 AM
Looks like patent link didn't fully
CYDY CytoDyn Inc
01/24/2025 11:56:11 PM
"...with simplified dosing regimens (3)
CYDY CytoDyn Inc
01/24/2025 11:27:17 PM
Applications were made just prior t (8)
CYDY CytoDyn Inc
01/24/2025 10:45:50 PM
New LL & AAV Patent applications: * (18)
CYDY CytoDyn Inc
01/10/2025 12:20:07 PM
This was prior to the now Sept/Oct (6)
CYDY CytoDyn Inc
12/10/2024 8:10:22 AM
This is how it went down. Now that (1)
CYDY CytoDyn Inc
12/10/2024 7:05:08 AM
Release of Claims = "I acted alone"
CYDY CytoDyn Inc
12/10/2024 2:02:32 AM
Separation Agreement and Release of (1)
CYDY CytoDyn Inc
12/09/2024 8:06:35 PM
Elevated levels of CCL5 indicate po (5)
CYDY CytoDyn Inc
12/09/2024 7:11:00 PM
Cervical -- if Max moves us into it (3)
CYDY CytoDyn Inc
12/09/2024 7:00:24 PM
" CYDY's Dr. Scott Hansen has one t (7)
CYDY CytoDyn Inc
12/08/2024 10:39:50 PM
Glioblastoma, an aggressive brain c (6)
CYDY CytoDyn Inc
12/08/2024 10:12:47 PM
Bill Gates has invested in Alzheime (6)
CYDY CytoDyn Inc
12/03/2024 9:09:59 PM
Dr. RP clarity: 7.9 Sponsored Resea (4)
CYDY CytoDyn Inc
12/03/2024 8:51:31 PM
Pestell came back because of what D (6)
CYDY CytoDyn Inc
11/27/2024 1:43:36 AM
RSV Center Court: Syneos Health and (6)
CYDY CytoDyn Inc
11/26/2024 3:10:19 PM
Company can have TA establish an av (1)
CYDY CytoDyn Inc
11/25/2024 7:19:11 PM
GSK angle? Dr. J was Pi on GSK's in (8)
CYDY CytoDyn Inc
11/25/2024 5:25:36 PM
Pestell / Blaxland / Lightseed: Dr. (2)
CYDY CytoDyn Inc
11/25/2024 9:06:36 AM
Max's team line-up: Oncology: Dr. U (4)
CYDY CytoDyn Inc
11/25/2024 8:40:28 AM
"...expertise will help CytoDyn max (2)
CYDY CytoDyn Inc
11/22/2024 9:12:37 AM
2. If HIV-1 positive, viral load mu (3)
CYDY CytoDyn Inc
11/20/2024 4:27:44 PM
Recover was easy form for even shar (2)
CYDY CytoDyn Inc
11/17/2024 6:14:23 PM
Started 2018 related to resevoir: H (3)
CYDY CytoDyn Inc
11/16/2024 9:44:31 PM
New amfAR grants support potential (5)
CYDY CytoDyn Inc
11/15/2024 8:32:02 PM
Stem cell transplantation and allog (2)
CYDY CytoDyn Inc
11/13/2024 10:54:11 PM
and demonstrated that allogeneic im (6)
CYDY CytoDyn Inc
11/13/2024 6:44:40 PM
Project Number 5R01AI129703-08 Form (8)
CYDY CytoDyn Inc
11/11/2024 4:04:44 PM
2021 10-Q.
CYDY CytoDyn Inc
11/11/2024 3:59:50 PM
In October 2021, the Company hired
CYDY CytoDyn Inc
11/10/2024 1:40:39 PM
& thing is....my loyalty is to my m (4)
CYDY CytoDyn Inc
11/10/2024 1:27:36 PM
Guess no truth based on SEC & trial (2)
CYDY CytoDyn Inc
11/10/2024 12:07:26 PM
Forgot...yea it's 2 yrs old, but it (2)
CYDY CytoDyn Inc
11/10/2024 12:05:17 PM
I've posted Agreement facts about t (4)
CYDY CytoDyn Inc
11/10/2024 12:53:42 AM
May 2022 on Pestell: Dr. Pestell an (7)
CYDY CytoDyn Inc
11/10/2024 12:10:34 AM
Breast Cancer & Cytodyn: Our Dr. Ue (7)
CYDY CytoDyn Inc
11/09/2024 11:03:15 AM
Him moving from Covid/HIV....into t (1)
CYDY CytoDyn Inc
11/09/2024 12:12:15 AM
Did not realize GSK's R&D focus is (5)
CYDY CytoDyn Inc
11/08/2024 10:40:57 PM
This part: Chronic immunosuppressio (1)
CYDY CytoDyn Inc
11/08/2024 7:08:58 PM
Forgot his UCLA bio: A more recent (1)
CYDY CytoDyn Inc
11/08/2024 6:36:11 PM
Our Dr. Otto Yang profile: He then (8)
CYDY CytoDyn Inc
11/07/2024 7:12:50 PM
She left L'oreal for GlaxoSmithKlin (5)
Go to page:
  • << First
  • < Previous
  • 8
  • 9
  • Next >

Recent Articles

  • Music Licensing, Inc. Enhances Transparency with Auditing Plans
  • AgriFORCE Enhances Compute Strategy at New Oyen Site
  • Aeries Technology, Inc. Reflects on Fiscal Year 2025 Growth
  • Taiwan Semiconductor's Market Performance: Opportunities and Challenges Ahead
  • Worldline Strengthens Risk Management with External Audits
  • Bit Digital's $163 Million Raise Signals Shift to Ethereum
  • Trump's Fragrance Line Criticized Amid Healthcare Cuts Concerns
  • Court Halts HHS Restructuring Amid Administrative Concerns
  • Transforming Spaces: Grasons’ Mid-Year Estate Sale Insights
  • Investors' Rights and Class Action in Sarepta Therapeutics Lawsuit
  • Discover the Top U.S. Cities for Affordable Living Choices
  • Hawkins Way Capital Expands Presence with New Hotel Acquisition
  • Understanding Your Legal Rights as Iovance Shareholders
  • Empowering Veterans: PVA and Food City Team Up for Donations
  • Aeries Technology Reports Stellar Performance and Future Plans
  • Why Propane Grills Are the Best Choice for Summer Gatherings
  • Join Cyclists in Support of Blood Cancer Patients on Lake Michigan
  • Transforming Lives: How Assisted Living Locators Boosts Freedom
  • Enhancing Home Fire Safety: Expert Gutter Guard Solutions
  • Explore Exciting Franchise Ventures with Executive Home Care
  • Elevance Health, Inc. Faces Legal Challenge: Know Your Rights
  • Appian Enhances Sales Leadership to Drive AI Growth Strategies
  • DriverZ.com Pioneers Florida's New Teen Driver Education Journey
  • FRE Nicotine Pouches and PBR: A Thrilling Partnership Ahead
  • RadCred's Quick Loan Service: Financial Relief for Everyone
  • Projected Growth of the PCB E-Scrap Recycling Market to 2032
  • ZenaTech's Expansion in Drone Services Benefits Agriculture Sector
  • Nerve Repair and Regeneration Sector Set to Skyrocket
  • Fueling Growth: SCR Power Controllers Poised for Market Surge
  • India's Robust Quartz Market Poised for Significant Growth
  • Growth of US Probiotics Market: Trends Boosting Digestive Health
  • Exciting Global Pre-Registration for New MMORPG Initiated
  • Exploring IoTeX's Ambitious Leap into Physical AI Innovation
  • RadCred's New Emergency Loan Program for Bad Credit Borrowers
  • ASM International's Upcoming Conference Call for Q2 Results
  • K12 Excels in Online Education with Prestigious Recognition
  • FG Communities Expands with New Property Acquisition
  • Taiwan Semiconductor's Growth Amidst Market Challenges and Risks
  • High Roller Technologies Forms Exciting Gaming Partnership
  • SEALSQ Leads the Charge Against Quantum Threats to Bitcoin
  • Inspira Technologies Achieves Significant Milestone with $22.5M Order
  • Assessing Dassault Aviation's Shares and Voting Rights Stats
  • HUD Announces Major Loan Sales: Exploring HVLS 2025 Offerings
  • Inspira Technologies Unveils Major Purchase Order and Growth Plans
  • Invesco Real Estate Income Trust Completes $85.7 Million Offering
  • WeRide Achieves Milestone with First Driverless Logistics Permit
  • Experience Coastal Bliss at Camp Margaritaville's Bungalows
  • Navigating Challenges in Today's Moving Landscape
  • Analyzing Recent Trends in GATX's Short Interest Dynamics
  • Insightful Analysis of Dell Technologies' Market Positioning
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site